Subscribe to RSS

DOI: 10.1055/s-0044-1788637
Antenatal Screening for Congenital Heart Disease: A Single Center 11-Year Study of the Incidence, Antenatal Detection Rate, and Outcomes of Fetal Cardiac Anomalies
Funding None.
Abstract
Objectives This article describes the incidence, detection rate, and birth outcomes of congenital heart disease (CHD) within a single center over an 11-year period.
Methods A database of patients diagnosed with CHD on antenatal ultrasound or within 12 months of delivery was collated from January 2010 to December 2020. A retrospective review of records was performed to establish the incidence of CHD and the antenatal detection rate (ADR). A Fisher's exact test was used to investigate the association between the type of CHD, the presence of a genetic abnormality, extracardiac anomalies, and the ADR.
Results The incidence of CHD was 4.3 per 1,000 maternities (n = 161). Fifty-five percent of anomalies were diagnosed antenatally. Twenty-seven percent underwent termination of pregnancy. Seventy-three percent of cases were alive at the end of follow-up. Patients with a major form of CHD were more likely to receive an antenatal diagnosis compared with those with other forms of CHD (64.9% vs. 39.1%, p 0.002). The presence of extracardiac abnormalities was associated with a higher ADR.
Conclusion The incidence of CHD was 4.3 per 1,000 maternities. Most major cardiac anomalies were diagnosed antenatally. Detection rates varied depending on the nature of the lesion and the presence of other congenital anomalies.
Implications for Clinical Practice Cardiac anomalies are the most common form of birth defect. Reported incidence rates lie between 4 and 20 per 1,000 live births. This study describes the incidence, pregnancy outcomes, and ADR of cardiac anomalies within one Scottish health board. It provides insight into the effectiveness of a national screening program in detecting CHD and the factors that influence ADR. Therefore, it can be used to more effectively counsel patients on the strengths and limitations of antenatal ultrasound for detecting CHD.
Note
This original research has never been presented or published.
Authors' Contributions
N.P. conceived and designed the study. I.C. and E.C. contributed to data collection. E.C. performed data analysis and wrote the manuscript with supervision from N.P. All authors have reviewed the final manuscript.
Ethical approval
This retrospective review of health records was registered with the local audit office and conformed to the ethical principles outlined in the Declaration of Helsinki.
Publication History
Article published online:
25 July 2024
© 2024. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bravo-Valenzuela NJ, Peixoto AB, Araujo Júnior E. Prenatal diagnosis of congenital heart disease: a review of current knowledge. Indian Heart J 2018; 70 (01) 150-164
- 2 Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39 (12) 1890-1900
- 3 Giang KW, Mandalenakis Z, Fedchenko M. et al. Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden. Eur J Prev Cardiol 2023; 30 (02) 169-176
- 4 Hunter LE, Simpson JM. Prenatal screening for structural congenital heart disease. Nat Rev Cardiol 2014; 11 (06) 323-334
- 5 Simpson JM. Impact of fetal echocardiography. Ann Pediatr Cardiol 2009; 2 (01) 41-50
- 6 NHS England. Fetal anomaly screening standards valid for data collected from 1 April 2022. Website: gov.uk. April 2022. Accessed December 1, 2022 at: http://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards/fetal-anomaly-screening-standards-valid-for-data-collected-from-1-april-2022
- 7 Fife NHS. About NHS Fife. Website: nhsfife.org. August 2021. Accessed December 2, 2022 at: http://www.nhsfife.org/about-us
- 8 KnowFife. Scottish Index of Multiple Deprivation 2020. Website: know.fife.scot. June 2020. Accessed December 7, 2023 at: https://know.fife.scot/__data/assets/pdf_file/0034/177667/SIMD-2020v2-KnowFife-Quick-Brief.pdf
- 9 European Commission. Website: EUROCAT. June 2023. Accessed November 12, 2023 at: https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en
- 10 Hoffman JI. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995; 16 (04) 155-165
- 11 Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol 1995; 26 (06) 1545-1548
- 12 van Velzen CL, Clur SA, Rijlaarsdam ME. et al. Prenatal detection of congenital heart disease–results of a national screening programme. BJOG 2016; 123 (03) 400-407
- 13 Singh Y, Mikrou P. Use of prostaglandins in duct-dependent congenital heart conditions. Arch Dis Child Educ Pract Ed 2018; 103 (03) 137-140
- 14 Royal College of Obstetricians and Gynaecologists. Termination of Pregnancy for Fetal Abnormality in England, Scotland and Wales. Website: rcog.org. May 2010. Accessed December 2, 2022 at: http://rcog.org.uk/media/21lfvl0e/terminationpregnancyreport18may2010.pdf
- 15 Kersting A, Kroker K, Steinhard J. et al. Psychological impact on women after second and third trimester termination of pregnancy due to fetal anomalies versus women after preterm birth–a 14-month follow up study. Arch Women Ment Health 2009; 12 (04) 193-201
- 16 Pavlicek J, Gruszka T, Polanska S. et al. Parents' request for termination of pregnancy due to a congenital heart defect of the fetus in a country with liberal interruption laws. J Matern Fetal Neonatal Med 2020; 33 (17) 2918-2926
- 17 Montaguti E, Balducci A, Perolo A. et al. Prenatal diagnosis of congenital heart defects and voluntary termination of pregnancy. Am J Obstet Gynecol MFM 2020; 2 (04) 100207
- 18 Garne E, Stoll C, Clementi M. Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17 (05) 386-391
- 19 Gardiner H, Chaoui R. The fetal three-vessel and tracheal view revisited. Semin Fetal Neonatal Med 2013; 18 (05) 261-268
- 20 Everwijn SMP, van Nisselrooij AEL, Rozendaal L. et al. The effect of the introduction of the three-vessel view on the detection rate of transposition of the great arteries and tetralogy of Fallot. Prenat Diagn 2018; 38 (12) 951-957
- 21 Public Health Scotland. Congenital Conditions in Scotland 2000 to 2020. Website: publichealthscotland. February 2023. Accessed August 5, 2023 at: http://publichealthscotland.scot/media/21100/2023-08-01_congenitalconditionsinscotland2020_technicalreport.pdf